$283.49
1.30% yesterday
NYSE, Oct 28, 09:00 pm CET

West Pharmaceutical Services, Inc. Stock price

$283.49
+23.17 8.90% 1M
+67.37 31.17% 6M
-44.07 13.45% YTD
-26.92 8.67% 1Y
+57.98 25.71% 3Y
+3.25 1.16% 5Y
+223.53 372.80% 10Y
+271.56 2,276.28% 20Y
NYSE, Closing price Tue, Oct 28 2025
-3.73 1.30%

Key metrics

Basic
Market capitalization
$20.4b
Enterprise Value
$20.0b
Net debt
positive
Cash
$628.5m
Shares outstanding
71.9m
Valuation (TTM | estimate)
P/E
41.9 | 41.5
P/S
6.8 | 6.6
EV/Sales
6.6 | 6.5
EV/FCF
52.7
P/B
6.7
Dividends
DPS
$0.82
Yield 1Y | 5Y
0.3% | 0.2%
Growth 1Y | 5Y
5.1% | 5.8%
Payout 1Y | 3Y
12.3% | 10.5%
Increased
25 Years
Financials (TTM | estimate)
Revenue
$3.0b | $3.1b
EBITDA
$790.2m | $749.9m
EBIT
$625.1m | $581.0m
Net Income
$491.7m | $491.2m
Free Cash Flow
$379.1m
Growth (TTM | estimate)
Revenue
4.9% | 6.3%
EBITDA
7.3% | 0.7%
EBIT
6.7% | -1.4%
Net Income
-1.6% | -0.3%
Free Cash Flow
17.9%
Margin (TTM | estimate)
Gross
35.6%
EBITDA
26.2% | 24.4%
EBIT
20.7%
Net
16.3% | 16.0%
Free Cash Flow
12.6%
Financial Health
Equity Ratio
73.6%
Return on Equity
18.4%
ROCE
18.0%
ROIC
16.7%
Debt/Equity
0.1
More
EPS
$6.8
FCF per Share
$5.3
Short interest
2.8%
Employees
11k
Rev per Employee
$270.0k
Show more

Is West Pharmaceutical Services, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,039 stocks worldwide.

West Pharmaceutical Services, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a West Pharmaceutical Services, Inc. forecast:

15x Buy
75%
5x Hold
25%

Analyst Opinions

20 Analysts have issued a West Pharmaceutical Services, Inc. forecast:

Buy
75%
Hold
25%

Financial data from West Pharmaceutical Services, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
3,018 3,018
5% 5%
100%
- Direct Costs 1,944 1,944
4% 4%
64%
1,074 1,074
7% 7%
36%
- Selling and Administrative Expenses 368 368
7% 7%
12%
- Research and Development Expense 71 71
3% 3%
2%
790 790
7% 7%
26%
- Depreciation and Amortization 165 165
10% 10%
5%
EBIT (Operating Income) EBIT 625 625
7% 7%
21%
Net Profit 492 492
2% 2%
16%

In millions USD.

Don't miss a Thing! We will send you all news about West Pharmaceutical Services, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

West Pharmaceutical Services, Inc. Stock News

Neutral
PRNewsWire
2 days ago
EXTON, Pa. , Oct. 27, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the launch of its West Synchrony™ Prefillable Syringe (PFS) System at CPHI Worldwide in Frankfurt, Germany. This innovative system marks a significant shift in drug delivery solutions by offering a fully verified p...
Neutral
PRNewsWire
5 days ago
EXTON, Pa. , Oct. 24, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following upcoming investor conferences:  UBS Global Healthcare Conference: Fireside chat at 9:30 AM ET on Tuesday, November 11, 2025, in Palm Beach Gardens, FL. Jefferies Global Healthc...
Positive
The Motley Fool
5 days ago
It was a beat-and-raise third quarter for the healthcare services specialist. It experienced broad growth throughout its product and service offerings.
More West Pharmaceutical Services, Inc. News

Company Profile

West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.

Head office United States
CEO Eric Green
Employees 10,600
Founded 1923
Website www.westpharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today